UAE Health Insurance Market Size, Share, Trends and Forecast by Type and Service Provider 2025-2033
UAE Health Insurance Market
Dublin, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The "UAE Health Insurance Market Size, Share, Trends and Forecast by Type, and Service Provider, 2025-2033" has been added to ResearchAndMarkets.com's offering.
The UAE health insurance market size was valued at USD 8.72 Billion in 2024. Projections indicate growth to USD 14.9 Billion by 2033, with a CAGR of 6.1% between 2025-2033. This growth is fueled by mandatory insurance regulations in Emirates like Abu Dhabi and Dubai, heightened demand for private healthcare services, and increasing awareness of health risk protection.
In parallel, factors such as population growth, an influx of expatriates, enhanced government investment in healthcare infrastructure, digitalization of insurance services, and improved consumer awareness are expanding the UAE health insurance market share.
In the UAE, the rising prevalence of chronic diseases is another market catalyst. The steady influx of expatriates and foreign workers has spurred demand for health insurance because UAE employers are often mandated to provide coverage, attracting global insurance providers to this dynamic market.
Technological advancements, especially the adoption of digital insurance platforms, have amplified accessibility and user convenience, further driving the market's growth. Moreover, educational campaigns have substantially raised awareness and understanding of health insurance benefits within the UAE populace.
UAE Health Insurance Market Trends/Drivers
Increasing government initiatives
The UAE government actively enhances healthcare accessibility and affordability via regulations and mandates. Compulsory employer-provided insurance has broadened insurance coverage across the population, catalyzing a rise in demand for health plans nationwide. Concurrently, government efforts to bolster healthcare infrastructure, integrate advanced medical technologies, and promote medical tourism enhance the market outlook.
These initiatives aim to enrich the overall healthcare ecosystem, indirectly strengthening the health insurance sector. Additionally, government-led educational campaigns underscore the significance of health insurance, facilitating market expansion.
Rising healthcare expenditure
Escalating healthcare costs are a significant market driver. With healthcare expenses rising, individuals and businesses increasingly seek financial protection, boosting demand for insurance that mitigates medical costs. Leading insurers are broadening coverage and benefits to ensure comprehensive access to quality medical services and exploring innovative reimbursement models like value-based care.
UAE Health Insurance Industry Segmentation
The market analysis addresses key trends and provides forecasts at the country level from 2025-2033, categorized by type and service provider.
Breakup by Type:
Individual
Group
The group type dominates, catering to organizations and associations with varied benefits, offering cost-effective options tailored to group-specific needs. Meanwhile, individual plans empower personal choice with diverse coverage levels and benefits, aligning with individual healthcare requirements and budgets.
Breakup by Service Provider:
Public
Private
The private sector commands the majority market share, offering diverse insurance plans with improved service quality through technological investments. Private insurers enhance customer experience through efficient claims processing and personalized support. Conversely, the public sector emphasizes equitable coverage, ensuring accessible healthcare across the UAE.
Competitive Landscape
Key market players innovate to meet evolving consumer and business demands, implementing digital solutions for policy management, claims submission, and telemedicine. They also expand healthcare provider networks and introduce specialized insurance products, ensuring comprehensive service to match the diverse needs of the market.
Key Questions Answered in This Report:
How big is the health insurance market in UAE?
What factors are driving the growth of the UAE health insurance market?
What is the forecast for the health insurance market in UAE?
Which segment holds the largest UAE health insurance type market share?
Key Attributes
Report Attribute
Details
No. of Pages
121
Forecast Period
2024-2033
Estimated Market Value (USD) in 2024
$8.7 Billion
Forecasted Market Value (USD) by 2033
$14.9 Billion
Compound Annual Growth Rate
6.1%
Regions Covered
United Arab Emirates
Key Topics Covered1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 UAE Health Insurance Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Breakup by Type5.5 Market Breakup by Service Provider5.6 Market Forecast5.7 SWOT Analysis5.8 Value Chain Analysis5.9 Porter's Five Forces Analysis5.10 PESTEL Analysis5.11 Price Analysis6 Market Breakup by Type6.1 Individual6.2 Group7 Market Breakup by Service Provider7.1 Public7.2 Private8 Government Regulations9 Strategic Recommendations10 Competitive Landscape10.1 Market Structure10.2 Key Players10.3 Profiles of Key PlayersFor more information about this report visit https://www.researchandmarkets.com/r/7gwyk9
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
UAE Health Insurance Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
7 minutes ago
- Medscape
High-grade Serous Carcinomas Follow Missed Salpingectomies
Opportunistic salpingectomy (OS) is feasible but not performed in almost a quarter of patients later diagnosed with high-grade serous carcinoma (HGSC), and about 40% of patients with a first-degree family history of ovarian cancer are not tested for genetic susceptibility prior to diagnosis, according to analysis of a retrospective review. These findings suggest that more work is needed to optimize HGSC prevention, particularly in light of limited treatment options, Sara Moufarrij, MD, lead author of a paper reporting these results, and colleagues wrote. 'While OS is not expected to prevent the 10% of ovarian cancers that arise from the ovarian stroma or germ cells, it is projected to reduce the risk of the most common, deadly type of ovarian cancer — HGSC — by nearly 80%,' the investigators wrote in JAMA Surgery . 'Robust data support OS as standard of care at the time of hysterectomy and as an alternative to tubal ligation. There are likely other opportunities for integrating OS into routine surgical practice, such as when postreproductive women undergo other elective abdominopelvic surgeries.' The new study combined a retrospective review of 1877 HGSC cases treated at Johns Hopkins and Memorial Sloan Kettering (2015-2021) with a national cross-sectional survey of 917 women in the Ovarian Cancer Research Alliance, including 348 with HGSC. Missed opportunity was defined as either a sterilization procedure (bilateral tubal ligation or hysterectomy without concurrent salpingectomy) at any age, or another abdominopelvic surgery at age 45 or older when salpingectomy could have been performed at least 1 year before diagnosis. The cutoff age of at least 45 years reflected data showing most women complete childbearing by that age. Among the 1877 patients in the retrospective cohort, 445 (23.7%) missed a surgical opportunity for salpingectomy. Of these, 54% were sterilization procedures and 46% were nongynecologic abdominopelvic surgeries, most often cholecystectomy, hernia repair, and bowel surgery. In the survey cohort, 11.5% reported a history of bilateral tubal ligation or hysterectomy without concurrent salpingectomy and 4% reported a history of abdominal surgery at 45 years or older without concurrent salpingectomy, meaning 15.5% missed an opportunity for the procedure. Moufarrij, of Memorial Sloan Kettering Cancer Center, New York City, and colleagues also assessed germline genetic testing in the retrospective cohort. They found that 111 patients (6%) had a first-degree family history of ovarian cancer. Among these patients, 43.2% were found to have a genetic susceptibility to ovarian cancer that was detected after diagnosis. How Does New Research Compare With Earlier Studies? Prior modeling suggested that universal OS during hysterectomy, in lieu of tubal ligation, could reduce ovarian cancer mortality by 14.5% and save $445 million annually. 'We really did not have a great sense of how many cancers could be prevented this way,' Gillian Hanley, PhD, associate professor, Department of Obstetrics and Gynecology, at University of British Columbia, Vancouver, British Columbia, Canada, told Medscape Medical News . This study provides 'one of the first clear estimates' of preventable HGSC cases, she said. 'By anchoring our analysis to the very population the intervention is designed to protect, we highlight the true magnitude of missed opportunity for prevention,' principal author of the new study, Rebecca L. Stone, MD, told Medscape Medical News . The study is also notable for including genetic testing and general abdominal surgery as forms of missed opportunity, not just gynecologic surgery, said Stone, of Johns Hopkins School of Medicine, Baltimore. How Can Clinicians Use These Findings in Practice? 'The take-home message is that we have an opportunity to dramatically reduce HGSC rates and save many lives,' Hanley said. 'We need to organize in order to take advantage of this opportunity.' This means educating candidate patients — even those without pathogenic variants that increase their risk — Hanley said, noting that 'when people are properly counseled, they overwhelmingly choose OS.' To realize the full potential for OS, however, these conversations, and the procedures themselves, will need to be conducted beyond the surgical gynecology service. 'High-volume abdominal procedures such as cholecystectomy, hernia repair, and bowel resections present the most logical next frontier for implementation,' Stone said. 'Engagement of general and colorectal surgeons is therefore a critical step in expanding the reach and impact of OS.' In an accompanying editorial, Lauren Gilgannon, MD and Linda R. Duska, MD, of University of Virginia School of Medicine, Charlottesville, Virginia, agreed but cautioned that achieving this goal will require 'novel and complex perioperative processes.' What Are Barriers to General Surgeons Performing These Procedures? The editorialists listed an array of financial, practical, and technical questions that will need to be addressed. These included: 'Will these be joint surgeries, or will the general surgeon perform them alone?' and 'How will the procedures be billed, and by whom?' 'Not all barriers to implementation are clear and they vary across hospitals, practices, patient demographics, socioeconomic status, and jurisdictions,' Gilgannon and Duska wrote. 'In order for this to work, general surgeons need to be compensated for doing this, so that is an important policy step,' Hanley said. 'They also need to feel comfortable and confident doing a salpingectomy, so offering general surgeons many different ways to learn salpingectomy has been important here in British Columbia, where we are actively expanding OS to general surgery.' Stone offered concrete steps to improve OS access in the US, including payer reform, guideline development, provider education, and better detection of tubal precancer. How Could Public Education Increase the OS Rate? Outside of the medical system, Hanley suggested that educating the public about OS can yield immediate and tangible benefits. 'If more people come in asking for salpingectomy, already knowing what it is and why they want it, then we make it much easier for surgeons to offer this as part of their practice,' she said. 'The time it takes to counsel patients will be much smaller if we can increase general knowledge about OS.' To this end, Stone envisions a future in which salpingectomy becomes a household word alongside other mainstays of preventive health. 'Education about salpingectomy must be woven into natural nodes of the healthcare journey, alongside conversations about contraception, pap smears, mammography, and colonoscopy,' she said.
Yahoo
36 minutes ago
- Yahoo
BetterRX Named to Inc. 5000 Again; Continues to Set New Standard.
SALT LAKE CITY, August 20, 2025--(BUSINESS WIRE)--Earlier this month, BetterRX was named to the 2025 Inc. 5000 list of fastest growing companies in the U.S. for the second year in a row, moving from No. 3554 to 2437. Over the past three years BetterRX has achieved an impressive 174% revenue growth as they continue to displace outdated PBMs and become the hospice pharmacy provider of choice. Because traditional PBMs were not designed for hospice workflows, they often contribute to medication delays, nurse frustration, and inflated pharmacy costs. BetterRX was built to solve these exact problems, with faster fulfillment, technology that saves nurses time, and lower medication spend. "We've built a category-defining platform that's transforming how hospice care teams work," said Ben Clarke, who served as President and then CEO during the company's rise. "I'm incredibly proud of what we've accomplished and of the team driving it forward." Over 345,000 Patients Served. 6.4 Million Prescriptions Delivered. BetterRX has now helped more than 345,000 patients receive timely, reliable medications and has processed over 6.4 million e-prescriptions nationwide. Its platform has delivered results that have set a new standard for how hospice pharmacy should be done: Nurses save 5 to 6 hours each week, allowing more time with patients Net Promoter Score of 90+, among the highest in healthcare tech Net revenue retention of 114% over the past three years "Hospice providers across the country are walking away from outdated pharmacy benefit managers and choosing BetterRX — a faster, simpler, and fully transparent platform purpose-built for hospice care," said Clarke. Scaling the Mission with BVP Forge To support its next phase of growth, BetterRX recently secured a strategic investment from BVP Forge, the growth fund of Bessemer Venture Partners. As part of this new chapter, Tim Tannert, a healthcare executive who began his career as a pharmacist and previously served as CEO of SoftWriters, has been appointed CEO. "BetterRX is a category-defining platform with clear proof of its impact on patient care and nurse efficiency," said Tannert. "Now we're scaling it. The need for better hospice pharmacy isn't going away. We're here to make sure no nurse wastes another hour and no patient waits in pain. I couldn't be more proud to work with this team on the next chapter of growth and to help more patients and families get the care they deserve." After 13 years in executive leadership, Clarke made the personal decision to step away from day-to-day operations. He will continue to support BetterRX as a board member. BVP Forge will provide strategic support through its ForgeEdge program, helping BetterRX scale operations, expand pharmacy partnerships, and deliver on its mission across the country. About BetterRX BetterRX is redefining hospice pharmacy care. As the leading hospice pharmacy platform, BetterRX combines best-in-class technology, the most reliable pharmacy fulfillment, and exceptional 24/7 clinical and customer support, setting a new standard for speed, efficiency, and trust in end-of-life care. BetterRX helps providers reduce medication costs, save critical nurse time, and deliver faster, better care to patients and families, because when it comes to hospice, every moment matters. Hospices of every size, from local agencies to national leaders, are turning to BetterRX as the trusted partner to optimize care, control costs, and transform the hospice experience for those who need it most. Visit View source version on Contacts James JarmanVP of Marketingjjarman@ 385-252-9033 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
36 minutes ago
- Yahoo
EliseAI Secures $250M Series E to Automate Healthcare and Housing, Hiring Hundreds to Fuel Expansion
Andreessen Horowitz leads round with participation from Bessemer Venture Partners, Sapphire Ventures, and Navitas Capital as EliseAI scales real-world enterprise AI NEW YORK, August 20, 2025--(BUSINESS WIRE)--EliseAI, the AI company automating complex healthcare and housing systems, today announced its Series E raise of $250 million. The round was led by Andreessen Horowitz (a16z), with participation from new investor Bessemer Venture Partners and existing investors Sapphire Ventures and Navitas Capital. With this new funding, EliseAI will rapidly expand its team to accelerate product innovation and impact, improving patient experiences, streamlining operations, and advancing AI-driven solutions for customers. The company is actively hiring across all departments including engineering, customer experience, sales and marketing, and strategy and operations, growing its office hubs in New York, San Francisco, Boston, and Chicago. "EliseAI is built on the belief that AI can dramatically improve how critical industries operate," said Minna Song, Co-Founder and CEO of EliseAI. "For an average American, healthcare and housing represent approximately 40% of household spending. These two systems are notoriously complex, outdated, and painful to navigate. And we're here to fix it with agentic AI. We're excited to partner with both new and returning investors to supercharge our growth and accelerate solutions that reduce costs and increase efficiency in the industries that matter most." Since raising its $75 million Series D in August 2024, EliseAI has grown from 150 to over 300 full-time employees and introduced new AI-powered products across both verticals. The company surpassed $100 million in Annual Recurring Revenue (ARR) earlier this year. Doubling down on healthcare, EliseAI is tackling one of the system's most expensive pain points: front-desk and call center operations. Healthcare administrative costs total in excess of $600 billion annually in the U.S. due to excessive manual tasks and limited investment in technology. EliseAI's automation platform handles complex healthcare workflows, from navigating multi-step scheduling and prior authorizations to capturing nuanced patient concerns – accurately, compliantly, and empathetically. By cutting overhead by up to 25%, slashing wait times, and reducing abandoned calls, EliseAI helps practices keep both staff and patients satisfied. "EliseAI has transformed our OB GYN call center operations by streamlining complex workflows, reducing patient wait times, improving operational efficiency, and elevating the customer experience," said Dr. Pierre Hage of Women's Health CT – Obstetrics & Gynecology. "With EliseAI, we're on the path to achieving 24/7/365 comprehensive practice management for our patients and staff." In the housing sector, EliseAI helps operators tackle rising costs, labor shortages, and high workforce turnover, which can exceed 40% annually. Its platform includes new products such as AI-Guided Tours, Lease Audits, the Fee Transparency Suite, and the Maintenance App, enabling property managers to streamline operations and improve resident experiences. The company supports over 600 owners and operators, including 75% of NMHC's Top 50 Operators. "Customers consistently describe EliseAI as the most exciting software solution in the industry. The company already powers 10% of the U.S. apartment market today, with a massive opportunity still ahead of them domestically and abroad as they begin to enter international markets," said Alex Immerman, partner, a16z Growth. "We're thrilled to be leading Elise's latest financing as they raise the standard for how people experience two of life's most essential services: housing and healthcare." About EliseAI EliseAI transforms complex healthcare and housing systems. By deeply integrating into workflows and automating operations, it makes them efficient and cuts costs for all. Its platform supports medical practices with patient scheduling, intake and front-desk operations and helps property managers handle leasing, maintenance and resident engagement. EliseAI replaces fragmented tools with one integrated system that reduces manual work and improves accessibility and experience for residents and patients alike. The company is based in New York with teams in San Francisco, Boston and Chicago. To learn more, visit About Andreessen Horowitz Andreessen Horowitz (a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. Founded in 2009, the firm manages multiple funds across stages, sectors, and geographies with over $46 billion in committed capital across funds. a16z invests in seed to growth-stage companies across AI, bio + healthcare, consumer, crypto, enterprise, fintech, games, infrastructure, and companies building toward American dynamism. For more information, visit View source version on Contacts Media Arianna ParanzinoEliseAIpress@ (408) 892-9207 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
